Altered activation of peripheral CD8+ T cells in pediatric Crohn's disease.

[1]  G. Veres,et al.  Altered calcium influx of peripheral Th2 cells in pediatric Crohn's disease: infliximab may normalize activation patterns , 2016, Oncotarget.

[2]  G. Schett,et al.  The effects of Kv1.3 and IKCa1 channel inhibition on cytokine production and calcium influx of T lymphocytes in rheumatoid arthritis and ankylosing spondylitis , 2016, Immunologic research.

[3]  H. Wulff,et al.  Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis. , 2014, Journal of Crohn's & colitis.

[4]  L. K. Hansen.  The role of T cell potassium channels, KV1.3 and KCa3.1, in the inflammatory cascade in ulcerative colitis. , 2014, Danish medical journal.

[5]  M. Dubinsky,et al.  Early Infliximab Trough Levels Are Associated with Persistent Remission in Pediatric Patients with Inflammatory Bowel Disease , 2014, Inflammatory bowel diseases.

[6]  J. Karczewski,et al.  Increased apoptosis of regulatory T cells in Crohn's disease. , 2014, Hepato-gastroenterology.

[7]  G. Toldi,et al.  Modulation of T Lymphocyte Calcium Influx Patterns Via the Inhibition of Kv1.3 and Ikca1 Potassium Channels in Autoimmune Disorders , 2013, Front. Immunol..

[8]  N. Palaniyar,et al.  NET balancing: a problem in inflammatory lung diseases , 2013, Front. Immun..

[9]  B. Molnár,et al.  Regulatory T cells in inflammatory bowel diseases and colorectal cancer. , 2012, World journal of gastroenterology.

[10]  Miles Parkes,et al.  Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis. , 2011, The Journal of clinical investigation.

[11]  G. Veres,et al.  Immune phenotype in children with therapy-naïve remitted and relapsed Crohn's disease. , 2010, World journal of gastroenterology.

[12]  S. Brand.  Crohn’s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn’s disease , 2009, Gut.

[13]  B. Vásárhelyi,et al.  Cytometry‐acquired calcium‐flux data analysis in activated lymphocytes , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[14]  M. Hoth,et al.  Calcium dependence of T cell proliferation following focal stimulation , 2007, European journal of immunology.

[15]  A. Griffiths,et al.  Evaluation of the Pediatric Crohn Disease Activity Index: A Prospective Multicenter Experience , 2005, Journal of pediatric gastroenterology and nutrition.

[16]  A. Kappeler,et al.  The role of activated cytotoxic T cells in inflammatory bowel disease. , 2000, Histology and histopathology.

[17]  E. Vasiliauskas,et al.  Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. , 1999, Gastroenterology.

[18]  Sartor Rb.  Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. , 1997 .